R 330.134 Chronic disease registry advisory board.
Rule 134. (1) The department shall create a chronic disease registry advisory board that
convenes at the time and place instructed by the director and considers proposals and
requests for the addition or removal of new reportable chronic diseases.
(2) The chronic disease registry advisory board shall consist of not less than 12 members
appointed by the director as follows:
(a) One individual representing the Michigan Health and Hospital Association.
(b) Two individuals representing the department’s public health administration.
(c) One individual representing a chronic disease organization.
(d) One individual representing a local health department.
(e) One individual representing the Michigan State Medical Society.
(f) One individual representing emergency medical services.
(g) One individual representing the chronic disease academic community.
(h) One individual representing a minority-serving community-based organization.
(i) One individual representing a tribal health agency.
(j) One individual representing a health system or hospital in this state.
(k) One individual representing the general public.
(3) In addition to those representatives named in subrule (2), the director may appoint
additional representatives to the board.
(4) As directed by the department, members of the board shall maintain and adhere to the
chronic disease registry advisory board’s bylaws, including member term limits, member
nominations, subcommittee formation, and other policies and procedures relevant to the
board’s ongoing operations.
(5) The board shall examine the public health need for the collection of this information
and may request assistance from the department to inform their recommendation regarding
the addition or removal of a chronic disease as needed. This information may include
requesting supplementary information from the individual or party proposing the chronic
disease, convening subject-matter experts or individuals with knowledge of the particular
condition, or assembling ad-hoc subcommittees.
(6) The board shall release its recommendations, including whether a chronic disease
should be made reportable, to the director of the department. The board may review or
modify their recommendation at any time prior to the director’s review. The director shall
then approve, modify, or reject the recommendations of the board.
History: 2024 AACS.
R 330.135 Investigation and quality assurance.
Rule 135. (1) The department, upon receiving a report under R 330.133, may request more
information from the reporting entity. The reporting entity must provide the information to
the department no later than 30 days after the request is made.
(2) The department shall consult with local health departments in the development of
procedures for processing chronic disease reports and conducting follow-up investigations
to ensure efficient, non-duplicative, and effective public health response.
(3) Requests by the department or local health departments for individual medical and
epidemiologic information to validate the completeness and accuracy of reporting are
Page 3